cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Elanco Animal Health Inc
7 own
8 watching
Current Price
$8.32
$0.08
(0.97%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
4,096.92M
52-Week High
52-Week High
24.93
52-Week Low
52-Week Low
7.9
Average Volume
Average Volume
6.54M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization4,096.92M
icon52-Week High24.93
icon52-Week Low7.9
iconAverage Volume6.54M
iconDividend Yield--
iconP/E Ratio--
What does the Elanco Animal Health Inc do?
Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals. The company offers companion animal disease prevention products, such as parasiticide products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and a range of food animal products used in ruminant and swine production. It sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine. The company was founded in 1954 and is headquartered in Greenfield, Indiana.
Read More
How much money does Elanco Animal Health Inc make?
News & Events about Elanco Animal Health Inc.
Zolmax
1month ago
Shares of Elanco Animal Health Incorporated (NYSE:ELAN Get Rating) have earned an average rating of Hold from the eight ratings firms that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating and five have given a hold rating to the company. The ...
Zolmax
3 months ago
Elanco Animal Health Incorporated (NYSE:ELAN Get Rating) has been given a consensus rating of Hold by the eight brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating and six have issued a hold rating on the company...
Business Wire
3 months ago
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2022 financial results on Tuesday, February 21, 2023. Elanco will also conduct a conference call on that day with the investment community and media to further detail the companys performance. The...
Ticker Report
3 months ago
Elanco Animal Health (NYSE:ELAN Get Rating) had its target price lowered by Morgan Stanley from $20.00 to $19.00 in a research note published on Monday morning, Benzinga reports. The firm currently has an equal weight rating on the stock. Several other equities research analysts also ...
Frequently Asked Questions
Frequently Asked Questions
What is Elanco Animal Health Inc share price today?
plus_minus_icon
Can Indians buy Elanco Animal Health Inc shares?
plus_minus_icon
How can I buy Elanco Animal Health Inc shares from India?
plus_minus_icon
Can Fractional shares of Elanco Animal Health Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Elanco Animal Health Inc stocks?
plus_minus_icon
What is today’s traded volume of Elanco Animal Health Inc?
plus_minus_icon
What is today’s market capitalisation of Elanco Animal Health Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Elanco Animal Health Inc?
plus_minus_icon
What percentage is Elanco Animal Health Inc down from its 52-Week High?
plus_minus_icon
What percentage is Elanco Animal Health Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$8.32
$0.08
(0.97%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Vaxcyte Inc
Vaxcyte Inc
$48.97
$0.38 (0.78 %)
Immunovant Inc
Immunovant Inc
$21.05
$-0.02 (-0.09 %)
Morphic Holding Inc
Morphic Holding Inc
$57.28
$0.90 (1.60 %)
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc
$35.56
$-0.43 (-1.19 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Vaxcyte Inc
Vaxcyte Inc
$48.97
$0.38 (0.78 %)
Immunovant Inc
Immunovant Inc
$21.05
$-0.02 (-0.09 %)
Morphic Holding Inc
Morphic Holding Inc
$57.28
$0.90 (1.60 %)
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc
$35.56
$-0.43 (-1.19 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00